Yu K T, Peters M A, Czech M P
J Biol Chem. 1986 Aug 25;261(24):11341-9.
Insulin-like growth factor I (IGF-I) receptors are partially purified from human placenta by sequential affinity chromatography with wheat germ agglutinin-agarose and agarose derivatized with an IGF-I analog. Adsorption specificity to this affinity matrix demonstrates that low coupling ratios of IGF-I analog to agarose yield preparations that are highly selective in purifying IGF-I receptor with minimal cross-contamination by the insulin receptor present in the same placental extracts. Incubation of the immobilized IGF-I receptor preparation with [gamma-32P]ATP results in a marked phosphorylation of the receptor beta subunits, which appear as a doublet of Mr = 93,000 and 95,000 upon electrophoresis on dodecyl sulfate-polyacrylamide gels. The 32P-labeled receptor beta subunit doublet contains predominantly phosphotyrosine and to a much lesser extent phosphoserine and phosphothreonine residues. The immobilized IGF-I receptor preparation exhibits tyrosine kinase activity toward exogenous histone. The characteristics of the IGF-I receptor-associated tyrosine kinase are remarkably similar to those of the insulin receptor kinase. Thus, prior phosphorylation of the immobilized IGF-I receptor preparation with increasing concentrations of unlabeled ATP followed by washing to remove the unreacted ATP results in a progressive activation of the receptor-associated histone kinase activity. A maximal (10-fold) activation is achieved between 0.25 and 1 mM ATP. The concentration of ATP required for half-maximal (30 microM) activation of the IGF-I receptor kinase is similar to that of the insulin receptor kinase. Like the insulin receptor kinase, the elevated kinase activity of the phosphorylated IGF-I receptor is reversed following dephosphorylation of the receptor beta subunit with alkaline phosphatase. Furthermore, the phosphorylation of the IGF-I receptor beta subunit doublet is enhanced by 7-8-fold when reductant is included in the reaction medium, as is observed for the insulin receptor kinase. Significantly, the dose responses of both receptor types to reductant are identical. Both of the 32P-labeled IGF-I receptor beta subunit bands are resolved into six matching phosphopeptide fractions when the corresponding tryptic hydrolysates are resolved by reverse phase high pressure liquid chromatography. Significantly, four out of the six phosphopeptide fractions derived from the trypsinized IGF-I receptor beta subunits are chromatographically identical to those from the tryptic hydrolysates of 32P-labeled insulin receptor beta subunit.(ABSTRACT TRUNCATED AT 400 WORDS)
胰岛素样生长因子I(IGF-I)受体通过与麦胚凝集素 - 琼脂糖和用IGF-I类似物衍生化的琼脂糖进行连续亲和层析,从人胎盘中部分纯化。对这种亲和基质的吸附特异性表明,IGF-I类似物与琼脂糖的低偶联率产生的制剂在纯化IGF-I受体时具有高度选择性,同时来自相同胎盘提取物中的胰岛素受体的交叉污染最小。将固定化的IGF-I受体制剂与[γ-32P]ATP孵育会导致受体β亚基发生明显的磷酸化,在十二烷基硫酸钠 - 聚丙烯酰胺凝胶上电泳时,其表现为分子量分别为93,000和95,000的双峰。32P标记的受体β亚基双峰主要含有磷酸酪氨酸,磷酸丝氨酸和磷酸苏氨酸残基的含量要少得多。固定化的IGF-I受体制剂对外源组蛋白表现出酪氨酸激酶活性。与胰岛素受体激酶相关的IGF-I受体酪氨酸激酶的特性非常相似。因此,用浓度递增的未标记ATP对固定化的IGF-I受体制剂进行预磷酸化,然后洗涤以去除未反应的ATP,会导致受体相关组蛋白激酶活性的逐步激活。在0.25至1 mM ATP之间可实现最大(10倍)激活。IGF-I受体激酶半最大激活(30 microM)所需的ATP浓度与胰岛素受体激酶相似。与胰岛素受体激酶一样,用碱性磷酸酶使受体β亚基去磷酸化后,磷酸化的IGF-I受体升高的激酶活性会逆转。此外,当反应介质中加入还原剂时,IGF-I受体β亚基双峰的磷酸化增强7 - 8倍,胰岛素受体激酶也有同样的现象。值得注意的是,两种受体类型对还原剂的剂量反应是相同的。当相应的胰蛋白酶水解产物通过反相高压液相色谱分离时,两个32P标记的IGF-I受体β亚基带都被解析为六个匹配的磷酸肽组分。值得注意的是,来自胰蛋白酶消化的IGF-I受体β亚基的六个磷酸肽组分中有四个在色谱上与32P标记的胰岛素受体β亚基的胰蛋白酶水解产物相同。(摘要截断于400字)